Analyst ratings and price targets can significantly influence investor sentiment and stock prices. The downgrade from Outperform to Neutral indicates a less optimistic outlook for Comerica, which could lead to selling pressure. Additionally, the lower price target suggests that the analyst believes the stock is currently overvalued, which could further discourage investment.